Figure 1.
(A) Schematic of 5′-end modification of oligonucleotides with AOCC-mediated bis-homo and bis-hetero conjugation. (B) Representative targeting and pharmacokinetic-modifier ligands.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.